APPLICATION
ANDA087744
TYPE
ANDA
ORIGINAL APPROVAL
1982-05-06
LATEST ACTION
1998-02-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CHLOROTHIAZIDE-RESERPINEDiscontinued
CHLOROTHIAZIDE 250MG, RESERPINE 0.125MG · TABLET · ORAL
Approval history
1998-02-25Manufacturing (CMC) · Supplement 12AP
1998-02-05Manufacturing (CMC) · Supplement 13AP
1994-03-07Manufacturing (CMC) · Supplement 11AP
1993-02-12Labeling · Supplement 9AP
1990-01-31Manufacturing (CMC) · Supplement 8AP
1989-06-22Labeling · Supplement 7AP
1988-05-04Labeling · Supplement 6AP
1986-03-25Manufacturing (CMC) · Supplement 4AP
1984-09-18Manufacturing (CMC) · Supplement 2AP
1982-05-06OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.